Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Hae Hyuk Jung"'
Autor:
Hae Hyuk Jung
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0297103 (2024)
It remains unclear what the blood pressure target is and at which point in life it is appropriate for antihypertensive treatment. This study aimed to determine age-specific systolic blood pressure (SBP) targets. In a nationwide cohort of 296,470 hype
Externí odkaz:
https://doaj.org/article/ce15f0e7c91247cfa7b270a1dd6e8e50
Autor:
Hae Hyuk Jung
Publikováno v:
Kidney Research and Clinical Practice, Vol 41, Iss 5, Pp 567-579 (2022)
Background Certain pharmacotherapies have shown to be effective for both cardiac and kidney outcomes. Although risk prediction is important in treatment decision-making, few studies have evaluated prediction models for composite cardiovascular and ki
Externí odkaz:
https://doaj.org/article/7cd4e59067374b3b9cf69f0b81104a11
Autor:
Kwang Jin Chun, Hae Hyuk Jung
Publikováno v:
Kidney Medicine, Vol 3, Iss 5, Pp 732-744.e1 (2021)
Rationale & Objective: There are few data on the absolute effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors, despite their importance in treatment decision making. We investigated absolute treatment effects according to baseline kidney dis
Externí odkaz:
https://doaj.org/article/891a53c9fdb04b54a17b4971b9140ecb
Statin use and outcome risks according to predicted CVD risk in Korea: A retrospective cohort study.
Autor:
Hae Hyuk Jung
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245609 (2021)
BackgroundThe validity of cardiovascular disease (CVD) risk calculators in decision for statin therapy has not been fully evaluated at a population level. This study aimed to examine the net benefits of statins according to predicted CVD risk.Methods
Externí odkaz:
https://doaj.org/article/f9b84a0d54b147f3abf26af2e0c43606
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171106 (2017)
Chronic kidney disease (CKD) is usually diagnosed using the estimated glomerular filtration rate (eGFR) or kidney damage markers. The urine dipstick test is a widely used screening tool for albuminuria, a CKD marker. Although the urine albumin:creati
Externí odkaz:
https://doaj.org/article/41eb2fc43b0c4f74900f5c795aa8812e
Autor:
Ji In Park, Hae Hyuk Jung
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172001 (2017)
The Global Burden of Disease 2010 and the WHO Global Health Estimates of years lived with disability (YLDs) uses disability-weights obtained from lay health-state descriptions, which cannot fully reflect different disease manifestations, according to
Externí odkaz:
https://doaj.org/article/6a06121b4bf041e2803035f24481b0e1
Autor:
Hae Hyuk Jung, Sunhwa Lee
Publikováno v:
Diabetes, Obesity and Metabolism. 22:243-253
AIMS To investigate the optimal fasting blood glucose (FBG) levels among individuals actively treated or untreated with antidiabetic drugs. METHODS In two population-based cohorts of Korean adults extracted from the National Health Information Databa
Autor:
Hae Hyuk Jung
Publikováno v:
Electrolytes & Blood Pressure : E & BP
The management of high blood pressure (BP) is crucial for improving outcomes in patients with chronic kidney disease (CKD). The updated Kidney Disease: Improving Global Outcomes 2021 BP guideline proposes treating adults with CKD to a target systolic
Publikováno v:
Heat Treat 2021: Extended Abstracts from the 31st Heat Treating Society Conference and Exposition.
Two stainless steel parts used in automotive engines are carburized in the course of their production to achieve desired properties. To reduce costs and improve product quality, the gas carburizing process that had been used was replaced by low-press
Autor:
Hae Hyuk Jung
Publikováno v:
JAMA Network Open
This cohort study examines the association of fasting blood glucose level with risk of kidney disease progression among patients with diabetes.
Key Points Question What is the optimal glycemic target associated with slowing of the progression of
Key Points Question What is the optimal glycemic target associated with slowing of the progression of